-
Thematic Analysis
NewUkraine Conflict Impact – Thematic Intelligence
Ukraine Conflict Impact Report Overview The large-scale Russian invasion of Ukraine in February 2022 has dramatically restructured strategic priorities within the global defense sector either by developing innovative defense capabilities, or the re-invigorating previously stagnant market segments. As the geostrategic implications of this conflict continue to reverberate across global markets, the primary lesson learned is the need to upscale production capacity and leverage cost-efficiency across all domains of modern warfare, with investments driving innovation of both technology and operations throughout...
-
Product Insights
Hemorrhagic Fever – Drugs In Development, 2023
Global Markets Direct’s, ‘Hemorrhagic Fever - Drugs In Development, 2023’, provides an overview of the Hemorrhagic Fever pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hemorrhagic Fever, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Infectious Diarrhea – Drugs In Development, 2023
Global Markets Direct’s, ‘Infectious Diarrhea - Drugs In Development, 2023’, provides an overview of the Infectious Diarrhea pipeline landscape. The report provides comprehensive information on the therapeutics under development for Infectious Diarrhea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Septic Shock – Drugs In Development, 2023
Global Markets Direct’s, ‘Septic Shock - Drugs In Development, 2023’, provides an overview of the Septic Shock pipeline landscape. The report provides comprehensive information on the therapeutics under development for Septic Shock, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Equine Encephalitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Equine Encephalitis - Drugs In Development, 2023’, provides an overview of the Equine Encephalitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Equine Encephalitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Eastern Equine Encephalitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Eastern Equine Encephalitis - Drugs In Development, 2023’, provides an overview of the Eastern Equine Encephalitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Eastern Equine Encephalitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Western Equine Encephalitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Western Equine Encephalitis - Drugs In Development, 2023’, provides an overview of the Western Equine Encephalitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Western Equine Encephalitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Sector Analysis
NewAutomated Homes Market Size, Share, Trends, and Analysis by Device Type, Region and Segment Forecast to 2030
Accessing the in-depth insights from the ‘Automated Homes’ report can help you: Make informed decisions about market entry, technology adoption, and project planning. Identify competitors' capabilities to stay ahead in the market. Identify promising device segments, growth trends, regional trends, and markets to expand your regional presence, product portfolio, and discover successful investment opportunities. Anticipate changes in demand and adjust business development strategies. Identify ongoing potential projects across regions. How is our ‘Automated Homes’ report different from other reports in the market? The report presents in-depth market sizing information...
-
Product Insights
Venezuelan Equine Encephalitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Venezuelan Equine Encephalitis - Drugs In Development, 2023’, provides an overview of the Venezuelan Equine Encephalitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Venezuelan Equine Encephalitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Periodontal Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Periodontal Disease - Drugs In Development, 2023’, provides an overview of the Periodontal Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Periodontal Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...